Teva Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 9,408.0 | 8,408.0 | 5,250.4 |
| Cost of Goods Sold | 4,531.0 | 4,149.0 | 2,769.8 |
| Gross Profit | 4,877.0 | 4,259.0 | 2,480.6 |
| Gross Profit Margin | 51.8% | 50.7% | 47.2% |
| SG&A Expense | 1,961.0 | 3,027.0 | 925.2 |
| Depreciation & Amortization | 521.0 | 431.0 | 242.5 |
| Operating Income | 2,395.0 | 801.0 | 1,312.9 |
| Operating Margin | 25.5% | 9.5% | 25.0% |
| Nonoperating Income | (42.0) | 84.0 | 29.5 |
| Nonoperating Expenses | -- | 179.0 | 33.8 |
| Income Before Taxes | 2,353.0 | 706.0 | 1,308.6 |
| Income Taxes | 397.0 | 155.0 | 236.2 |
| Net Income After Taxes | 1,956.0 | 551.0 | 1,072.4 |
| Continuing Operations | 1,952.0 | 546.0 | 1,072.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 1,952.0 | 546.0 | 1,072.3 |
| Total Net Income | 1,952.0 | 546.0 | 1,072.3 |
| Net Profit Margin | 20.7% | 6.5% | 20.4% |
| Diluted EPS from Total Net Income ($) | -- | -- | 1.59 |
| Dividends per Share | 0.33 | 0.32 | 0.22 |
This data is provided as per license from EDGAR Online
